PNC Financial Services Group’s Checkmate Pharmaceuticals, Inc. Common Stock CMPI Stock Holding History

PNC Financial Services Group’s Portfolio CMPI Stock Details CMPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-5,000	Closed	-$20K	–	4708
2021 Q3	$20K	Hold	5,000	–	–	﹤0.01%	3512
2021 Q2	$30K	Hold	5,000	–	–	﹤0.01%	3316
2021 Q1	$61K	Hold	5,000	–	–	﹤0.01%	2871
2020 Q4	$73K	Buy	+5,000	New	+$63.7K	﹤0.01%	2688

Other funds holding CMPI

venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

MVM

Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

CCP

Clough Capital Partners Boston, Massachusetts $1.04B AUM 49.7% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

PNC Financial Services Group's CMPI Position: Q4 2021 in Review

PNC Financial Services Group sold out of Checkmate Pharmaceuticals, Inc. Common Stock (CMPI) in Q4 2021, closing a stake of 5,000 shares — an estimated $20K sold.

PNC Financial Services Group first reported a position in CMPI in Q4 2020 and held it in 4 quarters. The position peaked at $73K in Q4 2020. 25 funds tracked by Wall St. Rank hold CMPI as of Q4 2021.

PNC Financial Services Group reported no remaining Checkmate Pharmaceuticals, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
PNC Financial Services Group sold 5,000 Checkmate Pharmaceuticals, Inc. Common Stock shares in Q4 2021, an estimated $20K.
PNC Financial Services Group first reported a position in Checkmate Pharmaceuticals, Inc. Common Stock in Q4 2020 and held it in 4 quarters.
PNC Financial Services Group's Checkmate Pharmaceuticals, Inc. Common Stock position peaked at $73K in Q4 2020.
25 funds tracked by Wall St. Rank held Checkmate Pharmaceuticals, Inc. Common Stock as of Q4 2021.

Based on PNC Financial Services Group's 13F filing for Q4 2021, filed 11 Feb 2022.